Decera Clinical Education Medical Specialties Podcast

IgG4-RD Expert Think Tank: Ensuring Timely Diagnosis and Evidence-Based Treatment to Prevent Relapse and Improve QoL

20 Oct 2026 ยท 46:19
Courses

Description

The key to effective IgG4-related disease (IgG4-RD) management is early recognition, accurate diagnosis, and timely treatment to prevent irreversible organ damage. Listen in to learn from expert faculty about recognizing common disease manifestations, distinguishing IgG4-RD from key mimicking conditions, assessing multiorgan involvement, and applying evidence-based treatment strategies to reduce relapse risk and improve patient outcomes.

Presenters

Yasmin G. Hernandez-Barco, MD
MGB Director of the Center for Pancreatic Disease
AMC Division of Gastroenterology, Hepatology, and Endoscopy
Outpatient Director, Complicated Pancreatitis Treatment Center
Assistant Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Guy Katz, MD, MS
Associate Physician, Division of Rheumatology, Inflammation, Immunity
Mass General Brigham
Instructor, Harvard Medical School
Boston, Massachusetts

Arezou Khosroshahi, MD
Professor of Medicine
Director of Clinical Trials
Rheumatology Division
Emory University School of Medicine
Atlanta, Georgia

Jai Radhakrishnan, MD, MS
Professor of Medicine
Clinical Director, Nephrology
Columbia University Vagelos College of Physicians and Surgeons
New York, New York

Chuck Vega, MD, FAAFP
Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Director, UCI Program in Medical Education for the Latino Community
Assistant Dean for Culture and Community Education
UC Irvine School of Medicine
Irvine, California

Link to full program:
https://bit.ly/4k6oQOe

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Comments

No comments yet โ€” be the first to write one.